News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
<Research>M Stanley Trims MNSO's TP to HKD41; Overseas Sales Growth to Accelerate in 2H25
While MINISO's (MNSO.US) (09896.HK) sales grew by 18.9% in 1Q25 (compared to guidance of 15-18%), its adjusted earnings fell by 4.3% YoY, missing expectations by 10%, Morgan St...
Reset
Send
The window will close in 5 seconds
<Research>M Stanley Trims MNSO's TP to HKD41; Overseas Sales Growth to Accelerate in 2H25
Close
Recommend
5
Positive
7
Negative
9
 
SHORT SELL
 
STOCK INFO

While MINISO's (MNSO.US)      (09896.HK)  +0.800 (+2.339%)    Short selling $42.09M; Ratio 22.325%   sales grew by 18.9% in 1Q25 (compared to guidance of 15-18%), its adjusted earnings fell by 4.3% YoY, missing expectations by 10%, Morgan Stanley wrote in its report.

In Morgan Stanley's estimates, MINISO's 2025 sales will rise by 21% YoY, with a CAGR of 18% in 2025-27, while its 2025 adjusted earnings will leap by 17% YoY, with a CAGR of 23% in 2025-27.

Related NewsMNSO 1Q NP RMB416M, Down 28.5% YoY
The broker kept an Overweight rating on the group but chopped its target price for its H-shares from HKD43 to HKD41 and for its US shares from USD22 to USD21.

Once the overseas market enters the peak season in 4Q25, Morgan Stanley anticipated that growth of DTC sales might accelerate along with improved profit margins.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2025-05-29 12:25.) (Real-time Streaming US Stocks Quote; Except All OTC quotes are at least 15 minutes delayed.)

AAStocks Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.